• Title/Summary/Keyword: 경구섭취량

Search Result 164, Processing Time 0.025 seconds

Reduction of Allergenicity of Wheat Flour by Enzyme Hydrolysis (효소 분해에 의한 밀가루의 항원성 저감화)

  • Park, Ju-Yeon;Ahn, Jeung-Yeub;Hong, Hee-Ok;Hahn, Young-Sook
    • Korean Journal of Food Science and Technology
    • /
    • v.36 no.1
    • /
    • pp.152-157
    • /
    • 2004
  • Gluten was extracted from domestic wheat flour using UTH buffer (4 M urea in 0.1 M Tris-HCl, pH 8.6) and validated by SDS-PAGE analysis for production of wheat flour products with reduced gluten content.. Anti-gluten polyclonal antibody was made by administering extracted gluten fraction on animal model. Anti-gluten serum titer of extracted gluten fraction was evaluated by ELISA, and that of antibody titer according to administration period. Anti-gluten sera were used for ELISA and immunoblot analysis before and after hydrolysis of gluten fraction at optimal pH and temperature condition for each protease. Gluten fraction separated by SDS-PAGE showed several bands covering 75 to 10 kDa, in which anti-gluten sera were 25, 34, and 45 kDa. Enzyme hydrolysis of gluten fraction revealed protein band sizes to be lower than 15 kDa. Content of pretense from bovine pancreas (b.p. protease) for gluten hydrolysis was estimated as 1 mg in 10 mL gluten fraction extracted for 4 hr.

Anti-obesity Effects of Extracts from Young Akebia quinata D. Leaves (어린 으름잎 추출물(Akebia quinata D. Leaves)의 항비만 효과)

  • Jeon, Yongseop;You, Yanghee;Jun, Woojin
    • Journal of the Korean Society of Food Science and Nutrition
    • /
    • v.43 no.2
    • /
    • pp.200-206
    • /
    • 2014
  • We investigated the in vitro and in vivo anti-obesity effects of extracts from young Akebia quinata D. leaves, including hot water (AQH) and 80% ethanol (AQE) extracts. The inhibitory effects of AQH and AQE on lipid accumulation in 3T3-L1 cells were examined by Oil Red O staining. Compared to control, lipid accumulation was significantly reduced by 18.3% with the treatment upon AQE at a concentration of $5{\mu}g/mL$. The levels of intracellular triglycerides and free glycerol were also reduced by 52.8% and 9.1% at the same concentration of AQE. The in vivo anti-obesity effect of AQE was evaluated in terms of body and white adipose tissue weights in ICR mice. Experimental groups were divided into the following five groups: normal diet (ND), high fat diet (HFD), high fat diet with 60 mg/kg/day of Orlistat (HFD-RF), high fat diet with 200 mg/kg/day of AQE (HFD-AL), and high fat diet with 600 mg/kg/day of AQE (HFD-AH). Feeding of HFD for eight weeks resulted in significant increases in body weight as well as weight gain compared to the ND group. HFD-AH group showed reduced body weight, weight gain, epididymal white adipose tissue weight, and perirenal white adipose weight as compared to the HFD group. These results indicate that AQE supplementation might have beneficial effects on anti-obesity by inhibiting lipid accumulation.

Development Toxicity Evaluation (랫드에서 표준 및 사료제한 시험에 의한 fluoroquinolone 항균제 DW-116의 발생독성평가)

  • 김종춘;윤효인;이희복;한상섭;정문구
    • Journal of Life Science
    • /
    • v.11 no.5
    • /
    • pp.447-456
    • /
    • 2001
  • We have recently demonstrated that the fluoroquinolone antibacterial DW-116 caused a significant developmental toxicity in rats. The present study was conducted to determine whether the development toxicity induced by DW-116 treatment was the result of malnutrition fro reduced food intake or the direct effects of test chemical on conceptuses. The test chemical was administered by gavage to pregnant rats from gestational days 6 through 16 at dose levels of 0 and 500 mg/kg/day. A pair-feeding study was also performed in which the pregnant rats received the same amount of diet consumed by the DW-116-treated pregnant rats. All dams were subjected to caesarean section on day 20 of gestation and their fetuses were examined for examined for external, visceral, and skeletal abnormalities. In this treatment group, the maternal toxicities included increased abnormal clinical signs, decreased maternal body weight, suppressed body weight gain during treatment and posttreatment periods, and reduced food intake. The significant developmental toxicities included increased fetal deaths, decreased live fetuses, reduced fetal body weight and placental weight, increased incidence of fetal abnormalities, and increased fetal ossification delay. In this pair-fed group, however, slight maternal toxicities including decreased body weight and suppressed body weight gain during treatment period were observed in comparison with the control group, and minimal development toxicities including reduced fetal and placental weights and increased fetal ossification delay were found. The number of fetal deaths and live fetuses, and the incidences of malformed fetuses and litters with affected fetuses were comparable to the control values. Based on the results, it could be concluded that the development toxicity observed in the treatment group is attributable to the direct effects of Dw-116 treatment, but not to the maternal malnutrition from reduced food consumption during pregnancy.

  • PDF

The Effect of Red-Yeast-Rice Supplement on Serum Lipid Profile and Glucose Control in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance (공복 혈당장애 및 내당능장애자에서 홍국의 섭취가 혈중지질 및 혈당 조절에 미치는 영향)

  • Kang, Mi-Ran;Kim, Ji-Young;Hyun, Yae-Jung;Kim, Hyae-Jin;Yeo, Hyun-Yang;Song, Young-Duk;Lee, Jong-Ho
    • Journal of Nutrition and Health
    • /
    • v.41 no.1
    • /
    • pp.31-40
    • /
    • 2008
  • This study was aimed at evaluating the effect of red-yeast-rice supplementation on cholesterol-lowering and glucose control in subjects with impaired fasting glucose (IFT) or impaired glucose tolerance (IGT). We conducted a doubleblind, placebo-controlled study with 3 groups; placebo, low dose group (red yeast rice 210.0mg/capsule, 2.52g/day) and high dose group (red yeast rice 420.0mg/capsule, 5.04g/day), which were randomly assigned to subjects with impaired fasting glucose or impaired glucose tolerance. We measured fasting serum concentrations of total-, LDL-, HDL-cholesterol, triglyceride, glucose, insulin, free fatty acid (FFA) and 2 h oral glucose tolerence test (OGTT) before and after the supplementation. Both low dose and high dose groups had significant decrease in LDL cholesterol and atherogenic index (AI) compared with placebo group (p<0.05). Additionally, total and HDL cholesterol improved significantly in high dose group compared with placebo group (p<0.05). Fasting serum glucose decreased in test groups and increased in placebo group after intervention. However, it was not significant differences. In subjects which fasting blood glucose is more than 110mg/dL, fasting glucose had a tendency to decrease in high dose group (p<0.1) and Hemoglobin A1c (HbA1c) had significant decrease in low dose group (p<0.05), while insulin and HOMA-IR had a tendency to increase in placebo group after intervention. Mean changes of glucose related parameters (fasting glucose, insulin, HOMA-IR) compared with placebo group did not show significant differences. In conclusion, subjects with impaired fasting glucose or impaired glucose tolerance were significantly improved in serum lipid profile by red yeast rice supplementation without serious side effects. These are more effective in the case of a high dose. The effects of red yeast rice supplementation on glucose control were insignificant.

Safety Evaluation of Epimedium koreanum Water Extract in Sprague-Dawley Rats (음양곽 물추출물의 독성 평가)

  • Kim, Joo-Wan;Lim, Mee-Kyung;Kim, Hong-Tae;Ku, Sae-Kwang;Chang, Hey-Sook;Oh, Tae-Ho;Lee, Keun-woo
    • Journal of Veterinary Clinics
    • /
    • v.27 no.2
    • /
    • pp.163-169
    • /
    • 2010
  • To evaluate of oral toxicity of Epimedium koreanum nakai (EKN) water extract, three doses of EKN water extract (10, 100 and 1000 mg/kg/day) were administered to healthy Sprague-Dawley rats for 4 weeks. The results showed that there are no abnormal signs during the experimental period. The weights of testis and epididymis were increased dose-dependently, but seminal vesicle was decreased compared with control group. In hematology and serum chemistry, changes were observed within the normal ranges. In histological finding, slight to moderated changes were found but those were commonly or rarely encountered in the normal rats. These results suggest that no observed adverse effect level (NOAEL) of the oral application of EKN was considered to be more than 1000 mg/kg in SD rats under the conditions employed in this study.

비허대서흡수공능적개변급운비치료적작용연구(脾虛大鼠吸收功能的改變及運脾治療的作用硏究) -비허(脾虛)의 동물모델 Rat의 흡수력 변화 및 운비법(運脾法)의 치료효과에 대한 연구

  • Son Won-Ryeong;Hae Jeong-Gun;Chuk Myeong-Geol;Ju Wi
    • The Journal of Pediatrics of Korean Medicine
    • /
    • v.15 no.1
    • /
    • pp.255-259
    • /
    • 2001
  • 본 연구는 운비요법(運脾療法)이 脾虛 동물모델 Rat의 흡수기능에 미치는 영향을 관찰하기 위한 것이다. 이혈평(利血平)으로 Rat의 비허(脾虛) 상태를 유발시킨 다음 최초로 비허(脾虛) 상태에서의 혈청 중 Zn 및 소장검막의 구조변화를 관찰하였고, 임상적으로는 소아의 편식증, 영양실조성 빈혈, 반복적인 소아감염증상(RRI) 등에 대한 운비법(運脾法)의 효과를 관찰하였다. 청결상태로 관리한 체중이 220-240g의 Wester계 웅성 Rat 15마리를 무작위로 각 5마리씩 정상군, 비허군(脾虛群), 중약투여군에 배분하여 3group으로 나누었다. 비허군과 중약투여군에는 모두 이혈평(利血平)을 소량으로 서서히 투여하였고, 중약투여군에는 동시에 중약 시럽(당장(糖漿))을 경구투여시켜 3주간 실험관찰하였다. 결과 : (1) 섭취량(g/일/마리) : 정상군은 22.1, 비허군(脾虛群)은 9.04, 중약투여군은 17.3으로 각각 나타났다. (2) 체중(g) : 정산군은 $284.2{\pm}32.51$, 비허군(脾虛群)은 $193{\pm}15.26$, 중약투여군은 $231.8{\pm}22.76$으로 각각 측정되었다. (3) 혈청 중 Zn함량(ug/1) : 정상군 $1911{\pm}993.8$, 비허군(脾虛群) $1094{\pm}249.4$, 중약투여군 $2599.8{\pm}1282.1$로 각각 측정되었다. 이와 같은 결과에서 중약투여군의 섭취량, 체중 및 혈청 중 Zn의 함량 모두 대조군에 비교하여 현저하게 개선되었음을 알 수 있다. (4) 소장의 정막구조 : 비허군(脾虛群)은 정상군에 비해 소장의 점막이 현저하게 얇고 융모상 돌기가 오그라들며 퇴화되는 변화를 나타냈고, 일부 융모상 돌기 끝의 상피세포는 국소적 괴사 및 퇴행성 변화를 일으키기도 하였다. 중약투여군은 이에 비해 소장점막이 거의 정상에 가깝게 회복되었다. 결론 : 운비요법(運脾療法)은 비허(脾虛) 동물모델에 대한 흡수기능의 개선에 효과가 있음을 본 실험에서 입증할 수 있었다.

  • PDF

Anti-diabetic Effect of the Methanolic Extract of Ligularia stenocephala Leaves in the Streptozotocin-induced Rat (스트렙토조토신으로 유도된 흰쥐에서 곤달비 추출물의 항당뇨 효과)

  • Choi, Jong-Won;Kim, Won-Bae;Nam, Jung-Hwan;Park, Hee-Juhn
    • Korean Journal of Plant Resources
    • /
    • v.20 no.4
    • /
    • pp.362-366
    • /
    • 2007
  • The leaves of Ligularia stenocephala (Compositae) are used as a vegetable food to treat anxiety, weakness and menstrual disorder and are said to be effective against diabetic disease in Korea. This research was aimed to develop this vegetable food as a functional food to treat diabetic disease. Oral administration of MeOH extract exhibited significant hypoglycemic and hypolipidemic effects in streptozotocin (STZ)-induced diabetic rats at 100 and 200 mg/kg dose. This extract inhibited the increase of body weight, water consumption, food intake, blood glucose, lowered atherogenic index, and overcome glucose intolerance in the STZ-treated rat. These results suggest that the leaves of Ligularia stenocephala could be developed as a functional food with anti-diabetic effect.

Studies on Protective Effect of Bupleurum falcatum Extract (SHI-1909) against Experimental Inflammtory Bowel Disease Model (시호추출물 (SHI-1909)의 염증성 대장염 실험동물 모델에 대한 치료효과)

  • Cho, Seong-Wan;Kim, Young-Kwon
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.10 no.3
    • /
    • pp.613-619
    • /
    • 2009
  • The Efficacy of SHI-1909 was investigated in comparision with predinisolone in acetic acid and Picrylsulfonic acid solution (TNBS)-induced rat inflammatory bowel disease (IBD) for 5 days. 7% Acetic acid and 5% TNBS solution were administered with polyethylene (P.E) tube inserted to rats intracolon, which causing colitis to the rats. The acetic acid and TNBS control group (the saline treated colitic rat) exhibited ulceration and inflammation of the distal colon with formation of granuloma and pathologic connections. We checked the inflammatory parameters like rat's weight, food intake quantity change during administration. After 5 days, we sacrificed the rats and checked the colon's length, ulcer and pathologic condition. Oral treatment with SHI-1909 resulted in significant recovery of macroscopic parameters like weight and diet intake change. Especially, SHI-1909 had a more potent effect than prednisolone on macroscopic colonic damage score. We can suggest that SHI-1909 could be a promising drug in the treatment of IBD.

A 90-day Safety Study (Repeated-Dose Oral Toxicity Study) of Genetically Modified ${\beta}$-Carotene Biofortified rice in Sprague-Dawley Rats (SD 랫드에서 베타카로틴강화미의 90일 반복투여 경구독성시험)

  • Park, Soo-Jin;Jeong, Mi-Hye;Lee, Si-Myoung;Kim, Mi-Kyoung;Park, Kyung-Hun;Park, Jae-Yup
    • The Korean Journal of Pesticide Science
    • /
    • v.15 no.3
    • /
    • pp.278-288
    • /
    • 2011
  • This study was conducted to evaluate the safety of ${\beta}$-carotene biofortified rice, a genetically modified organism (GMO) developed by Rural Development Administration. ${\beta}$-carotene biofortified rice were exposed on Sprague-Dawley rats for 13 weeks. All rats survived until the end of the exposure period. There were no biologically significant differences in body weight, feed and water consumption, weight gains and feed efficiency. There were no clinical signs of toxicity attributable to exposure to GM rice. Mild decreases in AST, ALT, TG levels were observed in Group II (25% GM rice (w/w) and Group III (50% GM rice (w/w), both in females and males. Results of histopathological changes treated with the ${\beta}$-carotene biofortified rice had no significant differences between the control and treatment groups. Based on these results, we deemed that genetically modified ${\beta}$-carotene biofortified rice was as safe as conventional rice.

The Content of Heavy Metals in Herbal Pills Used as General Processed Food and Risk Assessment of Heavy Metal Intakes (유통 환(丸)제품의 중금속 함량 및 위해성 평가)

  • Kim, Sung-Dan;Jung, Sun-Ok;Kim, Bog-Soon;Yun, Eun-Sun;Chang, Min-Su;Park, Young-Ae;Lee, Young-Chul;Chae, Young-Zoo;Kim, Min-Young
    • Journal of the Korean Society of Food Science and Nutrition
    • /
    • v.39 no.7
    • /
    • pp.1038-1048
    • /
    • 2010
  • The purpose of this study was to investigate some heavy metals (Pb, Cd, Cr, Cu, Hg) in 52 commercial herbal pills used as general processed food, to identify weekly heavy metal intakes from herbal pills and to evaluate their potential health risks. The samples were digested with a microwave and determinations of heavy metal residues were carried out by inductively coupled plasma mass spectrometry (ICP-MS) and mercury analyzer. The mean values of heavy metal contents for herbal pills used as general processed food were Pb 0.421 (0.032~1.630), Cd 0.157 (0.011~0.515), Cr 1.033 (0.112~9.933), Cu 6.923 (1.333~16.755), Hg 0.010 (0.001~0.088) mg/kg. Lead contents of herba and cadmium of algae, herba were high (ANOVA-test, p<0.05). Levels of cadmium concentrations exceeding WHO reference values (0.3 mg/kg) were observed in 10 samples (4 species). The significant correlation was observed between Pb and Cd (r=0.633, p<0.01). The weekly intakes of Pb, Cd, Cr, Cu, Hg from herbal pills were 1.112 (0.072~5.088), 1.614 (0.029~9.257), 3.000 (0.252~23.690), 0.182 (0.008~1.235), 0.220 (0.000~0.420)%, respectively, as compared with the Provisional Tolerable Weekly Intake (PTWI) established by Joint FAO/WHO Expert Committee for food safety evaluation. Our data suggest regulations limiting heavy metals in herbal pills used as general processed food.